|
MTRR expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.177210E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.661200E-01 |
| Normal-vs-Stage2 |
1.212600E-01 |
| Normal-vs-Stage3 |
6.800100E-02 |
| Normal-vs-Stage4 |
5.752800E-01 |
| Stage1-vs-Stage2 |
4.232200E-01 |
| Stage1-vs-Stage3 |
3.386000E-01 |
| Stage1-vs-Stage4 |
9.234800E-01 |
| Stage2-vs-Stage3 |
9.778200E-01 |
| Stage2-vs-Stage4 |
5.681000E-01 |
| Stage3-vs-Stage4 |
5.391000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.031820E-01 |
| Normal-vs-AfricanAmerican |
7.230000E-01 |
| Normal-vs-Asian |
9.779000E-01 |
| Caucasian-vs-AfricanAmerican |
3.507000E-01 |
| Caucasian-vs-Asian |
7.446800E-01 |
| AfricanAmerican-vs-Asian |
9.235200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.036200E-01 |
| Normal-vs-Female |
1.093550E-02 |
| Male-vs-Female |
1.601890E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.225600E-01 |
| Normal-vs-Extreme_Weight |
6.788400E-01 |
| Normal-vs-Obese |
7.892100E-02 |
| Normal-vs-Extreme_Obese |
5.362800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.320400E-01 |
| Normal_Weight-vs-Obese |
1.990000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.269400E-01 |
| Extreme_Weight-vs-Obese |
5.978000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.009800E-01 |
| Obese-vs-Extreme_Obese |
8.937900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.593800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.076000E-02 |
| Normal-vs-Age(61-80Yrs) |
4.399600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.548000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.683400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.928000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.196980E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.989800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.181700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.663610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.138000E-01 |
| Normal-VS-Type2 PRCC |
1.934410E-01 |
| Normal-VS-KIRP CIMP |
8.796400E-01 |
| Normal-VS-Unclassified PRCC |
1.963980E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.109600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.493200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.740400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.021600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.873600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.492400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.992200E-01 |
| Normal-vs-N1 |
1.868750E-01 |
| Normal-vs-N2 |
6.040100E-03 |
| N0-vs-N1 |
3.780600E-01 |
| N0-vs-N2 |
1.254780E-01 |
| N1-vs-N2 |
1.027050E-01 |
|
|
